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EDITORIAL FOCUS
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Historically, the lungs were considered sterile in healthy individuals, because standard bacterial culture methods failed to
consistently detect microbial organisms peaceably inhabiting
this niche (4). However, next-generation sequencing platforms
have recently identified diverse communities of microbial organisms that reside in healthy human lungs (2). It is now
generally accepted that, although at much lower density and
diversity than communities in the human gut, a distinct microbiome does exist in the respiratory tract (3). Some studies
further suggest the presence of a distinct lower airway microbiome with a composition that is distinct from the better
characterized communities in the upper airway (4). Associations between alterations in airway microbiota and airway
diseases are also becoming more apparent. It has been postulated that asthma and allergy represent interplay among consequences of abnormalities in microbial colonization and the
composition of bronchial airway microbiota. Numerous
studies have demonstrated that the composition of airway
microbiota in asthmatic patients is different from that of
healthy controls (1).
Bronchopulmonary dysplasia (BPD) is a multifactorial disease that results from the exposure of immature, preterm lungs
to several noxious stimuli (8). Recent data from Lal et al. (5),
our group (12), and others (9) indicate that human organs,
specifically airways, harbor a commensal microbiota at the
time of birth and possibly even in utero. Lal et al. (7) have
previously reported that the airways of preterm infants with
severe BPD are marked by distinct dysbiosis with relative
increased abundance of Gammaproteobacteria and decreased
Firmicutes, in particular the genus Lactobacillus (5). Multiple
other studies have reported associations between airway microbial dysbiosis and BPD or severity of BPD (10). Exploring
a variety of inputs connecting the airway microbiome to lung
development, Lal and colleagues (6) have also shown that
microbial dysbiosis may impact microRNA signaling in BPD.
In subsequent microbial metagenomics analysis, Lal et al. (5)
found that BPD-predisposed infants had elevated concentraAddress for reprint requests and other correspondence: K. A. Willis, The
Univ. of Tennessee Health Science Center, 853 Jefferson Ave., Room 201,
Memphis, TN 38163 (e-mail: kwill164@uthsc.edu).
http://www.ajplung.org

tions of metabolites involved in fatty acid activation, estrogen,
and androgen biosynthesis, thus suggesting that the airway
microbiome could alter lung development via alterations in
metabolites and dysregulation of downstream signaling pathways. Taken together, these data suggest that the early airway
microbiome modulates exosomal content of miRNA and induces changes in multiple metabolites. Despite these studies
demonstrating association between development of BPD and
microbial dysbiosis, the direction of causality between airway
injury during development and respiratory colonization by
organisms remained unsettled (8).
In this issue of American Journal of Physiology-Lung Cellular and Molecular Physiology, Lal and colleagues (2) developed a novel germ-free (GF) hyperoxia-exposed newborn
mouse model to interrogate their hypothesis that GF mice,
which are devoid of a microbiome, develop enhanced hyperoxia exposure-induced lung injury. In order to understand how
the airway microbiome impacts airway development, analyzing an environment devoid of microbiome is an essential
foundational step to define the pathogenic importance of the
airway microbiome to the development of the mouse lung. This
is the first report of the impact of the absence of a respiratory
microbiome on normal and abnormal lung development in a
mouse model. This study indicates that GF mice have similar
lung development and function in room air to specific pathogen
free (SPF) mice, which have an intact microbiome. However,
contrary to their hypothesis, the authors found that neonatal
hyperoxia exposure in mice with a microbiome resulted in
worse alveolar hypoplasia and a greater impairment of lung
mechanics as compared with GF mice. Decreased markers of
pulmonary inflammation [myeloperoxidase (MPO), IFN-␥,
and IL-1␤] were also seen in GF animals as compared with
SPF animals with hyperoxia exposure. Overall, the lung architecture of GF mice upon exposure to hyperoxia was relatively
protected compared with SPF mice (Fig. 1). These findings are
consistent with the group’s previous human neonatal airway
microbiome study where they found increased granulocytic
activity and a dysbiotic airway microbiome with a Proteobacterial preponderance in severe BPD patients (7). While some
caution should be exhibited due to the intrinsic immune disruption in GF mice (11), these results make us wonder if the
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Fig. 1. Germ-free mice are partially protected against hyperoxia exposureinduced lung injury. [Figure made in BioRender.]

presence of pathogenic microbiota in SPF and humanized mice
may potentiate the proinflammatory cascade in hyperoxia, thus
leading to a worse phenotype as compared with GF animals. In
the absence of a microbiome, GF animals may not mount a
sufficient inflammatory response and therefore may exhibit
phenotypic protection.
A major strength of this study is the comprehensive evaluation of lung structure and mechanics using multiple parameters in addition to echocardiography, cytokines, and MPO in a
newborn GF mouse model. The gnotobiotic hyperoxia facility
developed for this study was a significant technical feat, which
facilitated the maintaining continuous microbe-free conditions
in the lungs during the postnatal period while providing a
hyperoxic environment to induce BPD. A limitation of this
study, and that of the traditional newborn mouse hyperoxia
model in general, is the lack of antenatal confounder effects,
such as chorioamnionitis, fetal growth restriction, and steroid
use. Furthermore, evaluation of maternal and neonatal antibiotic exposure and the role of prenatal/maternal microbiome in
postnatal lung development is lacking and would make excellent next steps.
This report sets the stage for future studies evaluating the
complex processes involved in examining how the microbiome
affects lung development and injury. To overcome the intrinsic
immune disruption of GF mice (11), it will be important to
build on this current study by using gnotobiotic mice, which
have a defined microbiome amenable to systematic manipulation, to assess the therapeutic potential of altering the airway
microbiome composition.
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